Navigation Links
Cancer research presented at 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium

SAN ANTONIO More than 9,000 people from more than 90 countries will gather Dec. 8-12, 2010, at the Henry B. Gonzales Convention Center in San Antonio, Texas, for the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.

The symposium is the largest of its kind anywhere in the world. Each year it draws academicians, clinicians, survivors, patient advocates, industry and others interested in the advancement of breast cancer research to discuss and learn about new and late-breaking research, which includes experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and pre-malignant breast disease, as well as new findings from clinical trials.

The CTRC-AACR San Antonio Breast Cancer Symposium is a partnership between the Cancer Therapy and Research Center (CTRC) at UT Health Science Center San Antonio, the American Association for Cancer Research and Baylor College of Medicine.

"The driving force behind this collaboration is the shared mission of the organizations to advance progress against breast cancer," said Program Chairperson C. Kent Osborne, M.D., director of the Dan L. Duncan Cancer Center at the Baylor College of Medicine. "By combining their respective strengths, the San Antonio Breast Cancer Symposium encompasses the full spectrum of breast cancer research and facilitates the rapid transition of new knowledge into improved care for breast cancer patients."

The symposium begins on Wednesday, Dec. 8, with a full schedule of educational events. The opening plenary session begins the next day at 8:30 a.m. CT in Exhibit Hall D of the Henry B. Gonzales Convention Center.

In addition to the ongoing plenary session, there is a full industry exhibit hall and a program for survivors and breast cancer advocates. Press conferences will be held for registered members of the media.


Contact: Jeremy Moore
American Association for Cancer Research

Page: 1

Related medicine news :

1. FDA Panel to Vote on Drugs Said to Prevent Prostate Cancer
2. Finger length points to prostate cancer risk
3. FDA Panel to Vote on Drugs to Prevent Prostate Cancer
4. Cancer risk from medical radiation may have been overestimated
5. Annual breast cancer screening beginning at age 40 reduces mastectomy risk
6. Active surveillance for low-risk prostate cancer may offer better quality-of-life
7. Breast Cancer Rates Lower With Less Hormone Therapy: Study
8. Study Backs Active Surveillance for Low-Risk Prostate Cancer
9. Celebrex may help prevent some non-melanoma skin cancers
10. Experimental vaccine sets sights on lung cancer
11. Drop in breast cancer rates directly tied to reduced hormone therapy
Post Your Comments:
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United ... year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and ... havens have extremely low property-tax rates, which contributes to the relatively lower cost ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Dining at the University of California Berkeley, and other leading institutions in announcing ... buying power of institutions to change the way animals are raised for food. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
Breaking Medicine Technology: